Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver
Open Access
- 18 March 2015
- journal article
- research article
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 16 (5) , 690-698
Abstract
Background: Metastatic spread is the most common cause of cancer-related death in colorectal cancer (CRC) patients, with the liver being the mostly affected organ. Circulating tumor cells (CTCs) are a prognostic marker in stage IV CRC. We hypothesized that tumor burden in the liver correlates with CTC quantity. Methods: Blood (7.5 ml) was prospectively collected from 24 patients with novel stage IV CRC diagnosis. Baseline EpCAM+ CTCs were analyzed with the FDA-approved CellSearch® system. Clinicopathological data were collected, and hepatic tumor burden was determined by radiographic liver volumetry with contrast-enhanced CT scans. CRC primary tumors were immunohistochemically stained for EpCAM expression with BerEP4 monoclonal antibody. Statistical analyses were performed using 2-sample T-test, non-parametric Wilcoxon Rank-Sum test, and Fisher's exact test. Results: CTCs were detected n 17 (71%) of 24 patients. The overall mean CTC number as determined by EpCAM-based CellSearch® detection was 6.3 (SEM 2.9). High baseline CTC numbers (≥3) correlated significantly with a high tumor/liver ratio (≥30%), and with high serum CEA levels, as determined by two-sample T-test on log-transformed data and by Fisher's Exact test on categorical data analysis (P < 0.05). The CRC primary tumors were consistently expressing EpCAM by immunostaining. Conclusions: High tumor burden in the liver and high baseline serum CEA levels are associated with high number of baseline CTCs in stage IV CRC patients. Future studies should further investigate the biological role and expression patterns of single CTCs in cancer patients to further improve personalized treatment strategies.Keywords
This publication has 31 references indexed in Scilit:
- Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patientsJournal of Translational Medicine, 2012
- Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transitionBMC Cancer, 2012
- Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapseBritish Journal of Cancer, 2011
- Circulating tumor cells: approaches to isolation and characterizationJournal of Cell Biology, 2011
- Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor CellsClinical Cancer Research, 2010
- Circulating Tumor Cells and Colorectal CancerCurrent Colorectal Cancer Reports, 2010
- What's new on circulating tumor cells? A meeting reportBreast Cancer Research, 2010
- Circulating mutant DNA to assess tumor dynamicsNature Medicine, 2008
- Isolation of rare circulating tumour cells in cancer patients by microchip technologyNature, 2007
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004